Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence

Patricia Ormiga,1 Claudia A Hernández,2 Rogério de Lima Romeiro,3 Aude Bernardin,4 Fabio Sambatti Crema,5 Lauren Nakab,6 Lital Shklanovsky,7 Graeme Kerson8 1Clínica Patricia Ormiga, Rio de Janeiro, Brazil; 2CH Dermatologia, Medellin, Antioquia, Colombia; 3Faculdade São Leopoldo Mandic, Instituto São...

Full description

Saved in:
Bibliographic Details
Main Authors: Ormiga P, Hernández CA, de Lima Romeiro R, Bernardin A, Sambatti Crema F, Nakab L, Shklanovsky L, Kerson G
Format: Article
Language:English
Published: Dove Medical Press 2024-11-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/evaluating-the-properties-of-a-dual-effect-facial-injectable-from-prec-peer-reviewed-fulltext-article-CCID
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850194706572509184
author Ormiga P
Hernández CA
de Lima Romeiro R
Bernardin A
Sambatti Crema F
Nakab L
Shklanovsky L
Kerson G
author_facet Ormiga P
Hernández CA
de Lima Romeiro R
Bernardin A
Sambatti Crema F
Nakab L
Shklanovsky L
Kerson G
author_sort Ormiga P
collection DOAJ
description Patricia Ormiga,1 Claudia A Hernández,2 Rogério de Lima Romeiro,3 Aude Bernardin,4 Fabio Sambatti Crema,5 Lauren Nakab,6 Lital Shklanovsky,7 Graeme Kerson8 1Clínica Patricia Ormiga, Rio de Janeiro, Brazil; 2CH Dermatologia, Medellin, Antioquia, Colombia; 3Faculdade São Leopoldo Mandic, Instituto São Leopoldo Mandic, Área de Harmonização Orofacial, São Paulo, Brazil; 4Allergan Aesthetics, an AbbVie company, Pringy, France; 5Allergan Aesthetics, an AbbVie company, São Paulo, Brazil; 6Allergan Aesthetics, an AbbVie company, Irvine, CA, USA; 7Allergan Aesthetics, an AbbVie company, Lod, Israel; 8Allergan Aesthetics, an AbbVie company, Marlow, UKCorrespondence: Patricia Ormiga, Clínica Patricia Ormiga, Av. Ataulfo de Paiva, 204 – Sala 908, Leblon, Rio de Janeiro, Brazil, Tel +21 98805-1848, Email paormiga@gmail.com
format Article
id doaj-art-b25bb89d22474e54b830c97ce9f914fd
institution OA Journals
issn 1178-7015
language English
publishDate 2024-11-01
publisher Dove Medical Press
record_format Article
series Clinical, Cosmetic and Investigational Dermatology
spelling doaj-art-b25bb89d22474e54b830c97ce9f914fd2025-08-20T02:13:55ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152024-11-01Volume 172533253697174Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World EvidenceOrmiga PHernández CAde Lima Romeiro RBernardin ASambatti Crema FNakab LShklanovsky LKerson GPatricia Ormiga,1 Claudia A Hernández,2 Rogério de Lima Romeiro,3 Aude Bernardin,4 Fabio Sambatti Crema,5 Lauren Nakab,6 Lital Shklanovsky,7 Graeme Kerson8 1Clínica Patricia Ormiga, Rio de Janeiro, Brazil; 2CH Dermatologia, Medellin, Antioquia, Colombia; 3Faculdade São Leopoldo Mandic, Instituto São Leopoldo Mandic, Área de Harmonização Orofacial, São Paulo, Brazil; 4Allergan Aesthetics, an AbbVie company, Pringy, France; 5Allergan Aesthetics, an AbbVie company, São Paulo, Brazil; 6Allergan Aesthetics, an AbbVie company, Irvine, CA, USA; 7Allergan Aesthetics, an AbbVie company, Lod, Israel; 8Allergan Aesthetics, an AbbVie company, Marlow, UKCorrespondence: Patricia Ormiga, Clínica Patricia Ormiga, Av. Ataulfo de Paiva, 204 – Sala 908, Leblon, Rio de Janeiro, Brazil, Tel +21 98805-1848, Email paormiga@gmail.comhttps://www.dovepress.com/evaluating-the-properties-of-a-dual-effect-facial-injectable-from-prec-peer-reviewed-fulltext-article-CCIDnot required per author guidelines on research letters (https://www.dovepress.com/author-guidelines/article-types)
spellingShingle Ormiga P
Hernández CA
de Lima Romeiro R
Bernardin A
Sambatti Crema F
Nakab L
Shklanovsky L
Kerson G
Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
Clinical, Cosmetic and Investigational Dermatology
not required per author guidelines on research letters (https://www.dovepress.com/author-guidelines/article-types)
title Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
title_full Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
title_fullStr Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
title_full_unstemmed Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
title_short Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence
title_sort evaluating the properties of a dual effect facial injectable from preclinical data to real world evidence
topic not required per author guidelines on research letters (https://www.dovepress.com/author-guidelines/article-types)
url https://www.dovepress.com/evaluating-the-properties-of-a-dual-effect-facial-injectable-from-prec-peer-reviewed-fulltext-article-CCID
work_keys_str_mv AT ormigap evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT hernandezca evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT delimaromeiror evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT bernardina evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT sambatticremaf evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT nakabl evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT shklanovskyl evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence
AT kersong evaluatingthepropertiesofadualeffectfacialinjectablefrompreclinicaldatatorealworldevidence